Related Experiment Video

Updated: Jul 15, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Correction: The protein corona at the nano-bio interface: the need for standardized methodology and opportunities for

Getasew Shitaye1,2, Martina Dragone1, Zewdie Mekonnen2

  • 1Department of Environmental, Biological and Pharmaceutical Science and Technology, University of Campania "Luigi Vanvitelli" Caserta Italy getasewshitaye.ayalew@unicampania.it.

RSC Advances
|July 13, 2026
PubMed

Abstract:

[This corrects the article DOI: 10.1039/D6RA01255H.].

More Related Videos

Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
12:58

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Published on: September 12, 2019

Related Experiment Videos

Last Updated: Jul 15, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
12:58

Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy

Published on: September 12, 2019

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Articles linked to this work by shared authors, journal, and citation graph.

Antimicrobial Resistance in Six Priority Bacteria in Italy: Trends and Regional Variation, 2015-2024.

Antibiotics (Basel, Switzerland)·2026

Functional characterization of GplA (MSMEG-0394) reveals a novel determinant of glycopeptidolipids homeostasis in Mycobacterium smegmatis.

Frontiers in microbiology·2026

Insights into the molecular recognition of the second PDZ domain of ZO1 by coronavirus Envelope-derived peptides.

The FEBS journal·2026

Environmental Impact of β-Cyclodextrin Complexes with Herbicides: A Study on Solubility and Toxicity.

Molecules (Basel, Switzerland)·2026

Soluble zinc-induced amyloid β oligomers probed through fluorine NMR spectroscopy.

Communications chemistry·2026

A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems.

Frontiers in public health·2026

Multifunctional chito-oligosaccharide-and deferoxamine-modified GelMA-OHA hydrogel dressing with antibacterial, antioxidant, and pro-angiogenic activities for infected wound healing.

RSC advances·2026

Desulfurative cyanation of organosulfur compounds.

RSC advances·2026

Design and optimization of CdS-CeO2 composite electrodes for enhanced electrochemical performance for asymmetric supercapacitors.

RSC advances·2026

Enhancing ionic conductivity and interfacial stability of perovskite-type LLTO solid electrolytes via synergistic A-site Sr substitution and polymer layer engineering for safer lithium-ion batteries.

RSC advances·2026

Multiscale Transcriptomic Network Models of Parkinson's Disease at the Single Cell Level.

GigaScience·2026

Molecular Control of Neural Stem Cell Quiescence in the Adult Zebrafish Telencephalon: Established Mechanisms and an Integrative Hypothesis.

Glia·2026

Intracranial Neuroenteric Cyst in the Cerebellopontine Angle with Calcified Cyst Wall: A Rare Case Report.

Turkish neurosurgery·2026

Reversal of repetitive TMS-induced LTP-like plasticity by a novel compound in rats.

Frontiers in neural circuits·2026

PACS1 syndrome variant alters the proteomic landscape of developing cortical organoids.

iScience·2026

nHOTAIRM1 scaffolds ANXA11-dependent assemblies to drive axonal mRNA localization in human motor neurons.

Cell death and differentiation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us